Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | TDO2 | P48775 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.41 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1285074 | 1.00 | MEN1 (0.47) | MEN1KMT2AUGT2B7ALDH1A1MAPK1 | |
| SCHEMBL852720 | 1.00 | MEN1 (0.47) | MEN1KMT2AUGT2B7ALDH1A1MAPK1 | |
| SCHEMBL29626738 | 1.00 | MEN1 (0.47) | MEN1KMT2AUGT2B7ALDH1A1MAPK1 | |
| SCHEMBL1812811 | 0.84 | SLC6A2 (0.51) | ALDH1A1MAPK1IDO1TDO2CYP3A4 | |
| SCHEMBL9331663 | 0.83 | UGT2B7 (0.56) | MEN1KMT2AUGT2B7ALDH1A1CYP3A4 | |
| SCHEMBL2812852 | 0.83 | UGT2B7 (0.56) | MEN1KMT2AUGT2B7ALDH1A1CYP3A4 | |
| SCHEMBL9331659 | 0.83 | UGT2B7 (0.56) | MEN1KMT2AUGT2B7ALDH1A1CYP3A4 | |
| SCHEMBL9334664 | 0.83 | UGT2B7 (0.56) | MEN1KMT2AUGT2B7ALDH1A1CYP3A4 | |
| SCHEMBL13963168 | 0.83 | CYP3A4 (0.47) | ALDH1A1MAPK1IDO1TDO2CYP3A4 | |
| SCHEMBL11216092 | 0.83 | ALDH1A1 (0.42) | ALDH1A1MAPK1IDO1TDO2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024177860-A1 | IN CHEMICO TEST FOR TOXICITY | LEBRUN LABS LLC (US) | 2024-08-29 | — | — | WO | claimed |
| CN-114315658-B | Preparation method of sulfonate alkane ester | 宁波南大光电材料有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-114315658-A | Preparation method of sulfonate alkane ester | 宁波南大光电材料有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114213213-A | Preparation method of fingolimod impurity | 深圳市祥根生物医药有限公司 | 2022-03-22 | — | — | CN | claimed |
| US-4255340-A | Method for preparing an alkenyl-substituted dicarboxylic acid anhydride | TEXACO INC. (US) | 1981-03-10 | — | — | US | claimed |
| US-12559784-B2 | In chemico test for toxicity | LEBRUN LABS LLC (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260028336-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4558501-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | Arcus Biosciences, Inc. (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-3917527-B1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC (US) | 2025-04-23 | — | — | EP | disclosed |
| US-20250101489-A1 | IN CHEMICO TEST FOR TOXICITY | LEBRUN LABS LLC | 2025-03-27 | — | — | US | disclosed |
| CN-116693467-B | Thiazole amine MBL inhibitor and preparation method and application thereof | 四川大学 | 2025-02-14 | — | — | CN | disclosed |
| WO-2024177860-A1 | IN CHEMICO TEST FOR TOXICITY | LEBRUN LABS LLC (US) | 2024-08-29 | — | — | WO | disclosed |
| US-4544652-A | α-Hydroxyethylphosphinates, and their use as fungicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-10-01 | — | — | US | disclosed |
| US-4497960-A | Chiral, optically active compounds useful as protective groups for hydroxy, thiol and amino compounds | NOE CHRISTIAN (AT) | 1985-02-05 | — | — | US | disclosed |
| EP-0093010-A2 | Alpha-hydroxyethylphosphinates, and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-11-02 | — | — | EP | disclosed |
| EP-0083335-A1 | Optically active chiral compounds, process for their preparation and use of these compounds in the protection of functional -OH, -SH, -NH- groups, in the separation of racemates, in the preparation of optically active imidoester hydrochlorides and of optically active esters, in the preparation of optically enriched alcohols and in the preparation of optically active compounds by asymmetric induction | Noe, Christian, Dipl.-Ing. Dr. (AT) | 1983-07-06 | — | — | EP | disclosed |
| US-4255340-A | Method for preparing an alkenyl-substituted dicarboxylic acid anhydride | TEXACO INC. (US) | 1981-03-10 | — | — | US | disclosed |
| US-4064132-A | ANTIINFLAMMATORY AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1977-12-20 | — | — | US | disclosed |
| US-4060528-A | ANTIINFLAMMATORY | JANSSEN PHARMACEUTICA N.V. (BE) | 1977-11-29 | — | — | US | disclosed |
| US-4035376-A | ESTERS, AMIDES, HYDROXAMIC ACIDS, ANTIINFLAMMATORY | JANSSEN PHARMACEUTICA N.V. (BE) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028336-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | CBLB, CBL, CBLC | MEN1 4098/4885KMT2A 1974/4885UGT2B7 843/4885 |
| US-12559784-B2 | In chemico test for toxicity | ALPP, ALPI, CUTA | MEN1 2759/4885KMT2A 3500/4885UGT2B7 363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.